BR9808863A - Composições antiestrogênicas peptìdicas e métodos para tratar câncer de mama - Google Patents
Composições antiestrogênicas peptìdicas e métodos para tratar câncer de mamaInfo
- Publication number
- BR9808863A BR9808863A BR9808863-7A BR9808863A BR9808863A BR 9808863 A BR9808863 A BR 9808863A BR 9808863 A BR9808863 A BR 9808863A BR 9808863 A BR9808863 A BR 9808863A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- peptide
- breast cancer
- antiestrogenic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- High Energy & Nuclear Physics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçõES ANTIESTROGêNICAS PEPTìDICAS E MéTODOS PARA TRATAR CâNCER DE MAMA" A presente invenção refere-se a métodos e composições que compreendem peptídios nativos, mutagenizados especificamente no sítio e sintéticos compreendendo uma porção do receptor de estrogênio humano, ou co-ativador de receptor de estrogênio, e composições de ácido nucléico que codificam estas composições de polipeptídios. São também descritos métodos para sintetizar derivados de peptídio de fosfotirosila e maloniltirosila e seu uso como composições antiestrogênicas no tratamento de cânceres de mama, a preparação de composições farmacêuticas, kits para diagnósticos e o desenvolvimento de ensaios relacionados para uso em terapias antitumor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4354597P | 1997-04-14 | 1997-04-14 | |
PCT/US1998/007711 WO1998046250A1 (en) | 1997-04-14 | 1998-04-14 | Peptide antiestrogen compositions and methods for treating breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9808863A true BR9808863A (pt) | 2001-09-18 |
Family
ID=21927706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9808863-7A BR9808863A (pt) | 1997-04-14 | 1998-04-14 | Composições antiestrogênicas peptìdicas e métodos para tratar câncer de mama |
Country Status (5)
Country | Link |
---|---|
US (1) | US6306832B1 (pt) |
EP (1) | EP1005357A1 (pt) |
BR (1) | BR9808863A (pt) |
CA (1) | CA2286877A1 (pt) |
WO (1) | WO1998046250A1 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2786397B1 (fr) * | 1998-11-30 | 2003-01-10 | Synt Em | Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc |
FR2786398B1 (fr) * | 1998-11-30 | 2002-12-27 | Synt Em | Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide |
AU762006B2 (en) * | 1998-12-24 | 2003-06-19 | Ucb | Peptidic product, process and composition |
WO2001068145A2 (en) | 2000-03-15 | 2001-09-20 | Bristol-Myers Squibb Pharma Company | Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
US6818741B2 (en) * | 2000-06-01 | 2004-11-16 | Clf Medical Technology Acceleration Program, Inc. | Alpha-fetoprotein peptides and uses therof |
US7132400B2 (en) | 2001-06-02 | 2006-11-07 | Clf Medical Technology Acceleration Program, Inc. | Alpha-fetoprotein peptides and uses thereof |
AU2002363944A1 (en) * | 2001-11-20 | 2003-06-10 | Clf Medical Technology Acceleration Program, Inc. | Alpha-fetoprotein peptides and uses for imaging |
ATE540968T1 (de) | 2001-11-20 | 2012-01-15 | Albany Medical College | Alpha-fetoproteinpeptide und deren verwendungen |
US7943577B2 (en) * | 2001-11-20 | 2011-05-17 | Albany Medical College | Alpha-fetoprotein peptides and uses thereof |
US7385027B2 (en) * | 2003-01-07 | 2008-06-10 | University Of Kentucky Research Foundation | Membrane-permeable peptide capable of calpain inhibition |
CA2536946A1 (en) * | 2003-08-26 | 2005-03-03 | Board Of Regents, The University Of Texas System | Estrogen receptor modulators and uses thereof |
US20050255097A1 (en) * | 2004-01-26 | 2005-11-17 | Paul Reid | Modified venom and venom components as anti-retroviral agents |
US20060088843A1 (en) * | 2004-10-25 | 2006-04-27 | Reid Paul F | Modified venom and venom components as anti-retroviral agents |
US7964701B2 (en) | 2006-02-24 | 2011-06-21 | Albany Medical College | Alpha-fetoprotein peptides |
US7598342B2 (en) * | 2006-02-24 | 2009-10-06 | Albany Medical College | Alpha-fetoprotein peptides and uses thereof |
US20070225213A1 (en) * | 2006-03-23 | 2007-09-27 | Kosak Matthew K | Nucleic acid carriers for delivery of therapeutic agents |
US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
WO2008039482A2 (en) * | 2006-09-26 | 2008-04-03 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
US20100189776A1 (en) | 2007-03-16 | 2010-07-29 | Cancer Research Technology Ltd | Anti-androgen peptides and uses thereof in cancer therapy |
US9249189B2 (en) | 2010-01-18 | 2016-02-02 | Albany Medical College | Alpha-fetoprotein “ring and tail” peptides |
GB2496135B (en) * | 2011-11-01 | 2015-03-18 | Valirx Plc | Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis |
GB2513615A (en) | 2013-05-01 | 2014-11-05 | Cancer Rec Tech Ltd | Medical use |
US11110063B2 (en) | 2017-08-25 | 2021-09-07 | MAIA Pharmaceuticals, Inc. | Storage stable sincalide formulations |
US12129298B2 (en) | 2018-06-21 | 2024-10-29 | Daiichi Sankyo Company, Limited | Compositions including CD3 antigen binding fragments and uses thereof |
US20220177581A1 (en) | 2019-03-11 | 2022-06-09 | Memorial Sloan Kettering Cancer Center | Cd22 antibodies and methods of using the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4720455A (en) * | 1985-09-06 | 1988-01-19 | Pitman-Moore, Inc. | Progesterone assay method for mammals and monoclonal antibody therefor |
US5728534A (en) * | 1996-07-19 | 1998-03-17 | New England Medical Center Hospitals, Inc. | Methods for identifying cardiovascular therapeutic agents |
-
1998
- 1998-04-14 CA CA002286877A patent/CA2286877A1/en not_active Abandoned
- 1998-04-14 WO PCT/US1998/007711 patent/WO1998046250A1/en not_active Application Discontinuation
- 1998-04-14 EP EP98918327A patent/EP1005357A1/en not_active Withdrawn
- 1998-04-14 BR BR9808863-7A patent/BR9808863A/pt not_active IP Right Cessation
-
1999
- 1999-10-14 US US09/419,826 patent/US6306832B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1005357A1 (en) | 2000-06-07 |
CA2286877A1 (en) | 1998-10-22 |
AU7127398A (en) | 1998-11-11 |
AU737627B2 (en) | 2001-08-23 |
US6306832B1 (en) | 2001-10-23 |
WO1998046250A1 (en) | 1998-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9808863A (pt) | Composições antiestrogênicas peptìdicas e métodos para tratar câncer de mama | |
WO2001008636A8 (en) | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
BR9808881A (pt) | Compostos para imunoterapia de câncer de próstata e métodos para seu uso | |
HUP0500345A2 (hu) | Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására | |
BR9916207A (pt) | Composições e métodos para terapia e diagnósticode câncer ovariano | |
ATE403001T1 (de) | Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs | |
BR9907259A (pt) | Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso | |
BR0112542A (pt) | Composições e métodos papa a terapia e a diagnose de câncer ovariano | |
NO913211L (no) | Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer. | |
BR0113491A (pt) | Polinucleotìdeo e polipeptìdeo isolados, vetor de expressão, célula hospedeira, proteìna de fusão, métodos para estimular e/ou expandir células t especìficas para uma protéina de tumor, para estimular uma resposta imune em um paciente, para o tratamento de um câncer em um paciente e para inibir o desenvolvimento de um câncer em um paciente, população de célula t isolada, composição, e, uso de um componente. | |
BR0009505A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
DE69933998D1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
BR0210886A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal | |
ATE229073T1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
BR9808509A (pt) | Composições e métodos para o tratamento e diagnóstico do câncer de mama | |
BR9508467A (pt) | Composição de matéria peptídeo de ligação de receptor de somatostatina composição farmacéutica e processo para realizar uma cirurgia guiada por radiosótopos ou um procedimento de radiodiagnóstico ou radioterapéutico e para aliviar uma doença relacionada com somatostetina em um animal | |
WO2002088750A3 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
TR200103786T2 (tr) | Güğüs kanserinin tehisi ve imünoterapisi için bileşikler ve bunların kullanımı | |
WO1999002545A3 (en) | Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers | |
WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
BR0116763A (pt) | Anticorpos humanos especìficos para terapia seletiva do c ncer | |
BRPI0407031A (pt) | Composições e métodos para tratamento de câncer empregando igsf9 e liv-1 | |
HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007. |